Temenos AG (TMNSF) reported strong Q4 2024 results with a 12% year-on-year growth in Annual Recurring Revenue (ARR) and a 25% increase in free cash flow. The company achieved its strongest Sales ...

Barclays analyst Sven Merkt maintained a Hold rating on Temenos (TMNSF – Research Report) today and set a price target of CHF74.00. The ...

In a report released today, Pavan Daswani from Citi maintained a Hold rating on Temenos (TMNSF – Research Report), with a price target of ...

Ladies and gentlemen, welcome to the Temenos Q4 2024 Results Conference Call and Live Webcast. I would like to remind you that all participants will be in listen-only mode, and the conference is ...

By 2028, Temenos expects ARR to exceed $1.2 billion, EBIT to reach $450 million, and free cash flow to grow to $400 million, reflecting compound annual growth rates of 13%, 10%, and 16%, respectively.

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Temenos AG develops, markets, and sells integrated banking software systems ...

The Swiss-based company now expects annual recurring revenue (ARR) to reach at least $1.2 billion in its 2028 financial year. Previously in November it had said it was targeting ARR of more than $1.3 ...

Banking software company Temenos on Tuesday said that a closely watched measure of revenue would grow at least 12% in 2025, as it reported 2024 full-year and fourth quarter earnings that were in line ...

On Tuesday, Stifel, a financial services firm, increased the price target for Temenos AG (TEMN:SW) (OTC: TMSNY) to CHF100 from the previous CHF80 while maintaining a Buy rating on ...

On Thursday, Citi revised its price target for Temenos AG (TEMN:SW) (OTC: TMSNY), a leading banking software company, reducing it to CHF65 from CHF68 while maintaining a Neutral ...

Banking software company Temenos on Tuesday lowered its full year 2028 targets to reflect the $400 million sale of its fund administration software business Multifonds, announced earlier in February.